Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Retatrutide has not yet received marketing authorisation from the MHRA or EMA and remains under clinical investigation
BPC-157 + TB-500 Peptide Blend Synthesized and Lyophilized in Canada by Koi Peptides Domestic Co-Lyophilization at a Canadian Facility BPC-157 and TB-500 are produced on independent solid-phase peptide synthesis runs at Koi's Canadian production partner, each purified to clear the 99% specification before being combined at a 1:1 mass ratio for a single co-lyophilization cycle
Pancreatic Cancer Pancreatic cancer is one of the most aggressive malignancies, and is the seventh cause of cancer-related mortality worldwide, with a 5-year survival rate of about 5% (Bray et al., 2017)
cash-pay pricing programs for patients without coverage Currax (Contrave): Savings card available for eligible patients Practice Infrastructure for Insurance Navigation Building a systematic approach to insurance verification and prior authorization improves efficiency and patient satisfaction
US$ 22.18
US$ 25.57
US$ 20.56
US$ 26.64
US$ 23.27
US$ 20.17
